In addition, downregulated TGFBI, acting as a tumor suppresser, can cause tumor growth in breast cancer (Li et al., 2012), lung cancer (Wen et al., 2011a), and mesothelioma (Wen et al., 2011b). Here, TGFBI is linked to lung carcinoma.